甘油三酯葡萄糖指数对急性心肌梗死患者MACE事件的预测价值

贾海燕, 张卫锋, 贾辛未, 解俊敏, 王艳飞, 张靖, 吴艳民, 祖玉刚, 刘砂, 刘毅, 王潇伟

PDF(822 KB)
PDF(822 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (10) : 1146-1153. DOI: 10.13406/j.cnki.cyxb.003598
临床研究

甘油三酯葡萄糖指数对急性心肌梗死患者MACE事件的预测价值

作者信息 +

Value of triglyceride glucose index in predicting major adverse cardiovascular events in patients with acute myocardial infarction

Author information +
History +

摘要

目的 探讨甘油三酯葡萄糖指数(triglyceride glucose index,TyG指数)对急性心肌梗死患者发生主要心血管不良事件(major adverse cardiovascular events,MACE)的预测价值。 方法 2013年10月至2018年10月于河北大学附属医院心血管内科就诊且行冠脉造影的急性ST段抬高型心肌梗死(st-elevation myocardial infarction,STEMI)患者1 092例,依据TyG指数分为T1组(TyG指数≤9.58,533例)和T2组(TyG指数>9.58,559例)。随访4年,观察心源性死亡、非致死性心肌梗死、缺血驱动的靶血管重建术和心力衰竭再住院的发生率。另外依据MACE事件的发生与否分组,进行多因素COX分析评估MACE事件发生的危险因素。 结果 在4年随访期间,T1(TyG指数≤9.58,533例)和T2组(TyG指数>9.58,559例)相比,缺血驱动的靶血管血运重建、心力衰竭再住院率、非致死性急性心肌梗死比较,差异无统计学意义(P>0.05)。相较于T1组,T2组心源性病死率更高,差异有统计学意义(χ2=26.696,P<0.001)。TyG指数作为连续变量和MACE事件密切相关(HR=4.152;95%CI=1.972~8.744,P<0.001)。TyG指数(HR=4.178,95%CI=2.487~7.020,P<0.001)、性别(HR=1.802,95%CI=1.232~2.637,P=0.002)、白细胞计数(HR=1.038,95%CI=1.001~1.007,P=0.042)、肌钙蛋白Ⅰ(HR=1.027,95%CI=1.014~1.040,P<0.001)、肌酸激酶同工酶(HR=1.016,95%CI=1.007~1.024,P<0.001)、空腹血糖(HR=1.131,95%CI=1.075~1.191,P<0.001)、射血分数(HR=0.977,95%CI=0.962~0.992,P=0.003)、多支血管病变(HR=1.573,95%CI=1.303~1.898,P<0.001)、支架个数(HR=1.377,95%CI=1.072~1.769,P=0.012)为MACE事件发生的独立危险因素。 结论 TyG指数对急性心肌梗死患者MACE事件有较好预测价值,TyG指数、性别、白细胞计数、肌钙蛋白Ⅰ、肌酸激酶同工酶、空腹血糖、射血分数、多支血管病变、支架个数联合预测效果更好,联合预测的特异度0.775,敏感度0.667,ROC曲线下面积为0.739。

Abstract

Objective To investigate the value of triglyceride glucose index(TyG index) in predicting major adverse cardiovascular events(MACE) events in patients with acute myocardial infarction. Methods A total of 1 092 patients with acute ST-elevation myocardial infarction(STEMI) who were admitted to Department of Cardiology,Affiliated Hospital of Hebei University,from October 2013 to October 2018 and underwent coronary angiography were enrolled as subjects,and according to the TyG index,they were divided into T1 group(533 patients with TyG index ≤9.58) and T2 group(559 patients with TyG index >9.58). The patients were followed up for 4 years to observe the incidence rates of cardiac death,nonfatal myocardial infarction,ischemia-driven target vessel revascularization,and rehospitalization due to heart failure. In addition,the patients were divided into groups according to the presence or absence of MACE,and a multivariate Cox analysis was performed to investigate the risk factors for MACE. Results During the 4-year follow-up,there were no significant differences between the T1 group and the T2 group in ischemia-driven target vessel revascularization,rehospitalization rate due to heart failure,and nonfatal acute myocardial infarction(P>0.05). Compared with the T1 group,the T2 group had a significantly higher cardiac mortality rate(χ2=26.696,P<0.001). As a continuous variable,TyG index was closely associated with MACE(hazard ratio[HR]=4.152,95%CI=1.972-8.744,P<0.001),TyG index(HR=4.178,95%CI=2.487-7.020,P<0.001),sex(HR=1.802,95%CI=1.232-2.637,P=0.002),white blood cell count(HR=1.038,95%CI=1.001-1.007),P=0.042),troponin Ⅰ(HR=1.027,95%CI=1.014-1.040,P<0.001),creatine kinase isoenzyme(HR=1.016,95%CI=1.007-1.024,P<0.001),fasting blood glucose(HR=1.131,95%CI=1.075-1.191,P<0.001),ejection fraction(HR=0.977,95%CI=0.962-0.992,P=0.003),multi-vessel disease (HR=1.573,95%CI=1.303-1.898,P<0.001),and number of stents(HR=1.377,95%CI=1.072-1.769,P=0.012) were independent risk factors for MACE. Conclusion TyG index has a good value in predicting MACE in patients with acute myocardial infarction,and the combination of TyG index,sex,white blood cell count,troponin I,creatine kinase isoenzyme,fasting blood glucose,ejection fraction,multi-vessel lesion,and number of stents has a better predictive effect,with a specificity of 0.775,a sensitivity of 0.667,and an area under the ROC curve of 0.739.

关键词

急性ST段抬高型心肌梗死 / 心源性死亡 / 心力衰竭

Key words

acute ST-elevation myocardial infarction / cardiac death / heart failure

中图分类号

R54

引用本文

导出引用
贾海燕 , 张卫锋 , 贾辛未 , . 甘油三酯葡萄糖指数对急性心肌梗死患者MACE事件的预测价值. 重庆医科大学学报. 2024, 49(10): 1146-1153 https://doi.org/10.13406/j.cnki.cyxb.003598
Jia Haiyan, Zhang Weifeng, Jia Xinwei, et al. Value of triglyceride glucose index in predicting major adverse cardiovascular events in patients with acute myocardial infarction[J]. Journal of Chongqing Medical University. 2024, 49(10): 1146-1153 https://doi.org/10.13406/j.cnki.cyxb.003598

参考文献

1
胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志201934(3):209-220.
Hu SS Gao RL Liu LS,et al. Summary of the 2018 report on cardiovascular diseases in China[J]. Chin Circ J201934(3):209-220.
2
Panduranga P Al-Rashidi M Al-Hajri F. In-hospital and one-year clinical outcome of percutaneous coronary intervention in a tertiary hospital in OmanOman PCI registry[J]. Oman Med J201732(1):54-61.
3
Roumeliotis A Claessen B Sartori S,et al. Impact of race/ethnicity on long term outcomes after percutaneous coronary intervention with drug-eluting stents[J]. Am J Cardiol2022167:1-8.
4
Liu SJ Jiang HC Dhuromsingh M,et al. Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention:a systematic review and meta-analysis from 18,715 individuals[J]. Front Cardiovasc Med20229:1013501.
5
Zhang ZS Qin SQ Wang R,et al. Prognostic factors in young patients with ST-segment elevation myocardial infarction[J]. Coron Artery Dis202334(5):298-305.
6
Liang MT Pang Y Gao LL,et al. Clinical risk factors and outcomes of young patients with acute ST segment elevation myocardial infarction:a retrospective study[J]. BMC Cardiovasc Disord202323(1):353.
7
Huang LY Zhang J Huang Q,et al. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction:a retrospective study under the China chest pain center (standard center) treatment system[J]. BMC Cardiovasc Disord202323(1):198.
8
Yaribeygi H Farrokhi FR Butler AE,et al. Insulin resistance:review of the underlying molecular mechanisms[J]. J Cell Physiol2019234(6):8152-8161.
9
Di Pino A DeFronzo RA. Insulin resistance and atherosclerosis:implications for insulin-sensitizing agents[J]. Endocr Rev201940(6):1447-1467.
10
Barzegar N Tohidi M Hasheminia M,et al. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up:Tehran Lipid and Glucose Study[J]. Cardiovasc Diabetol202019(1):155.
11
Won KB Lee BK Park HB,et al. Quantitative assessment of coronary plaque volume change related to triglyceride glucose index:the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging(PARADIGM) registry[J]. Cardiovasc Diabetol202019(1):113.
12
Thai PV Tien HA Van Minh H,et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes[J]. Cardiovasc Diabetol202019(1):137.
13
Mao Q Zhou DL Li YM,et al. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome[J]. Dis Markers20192019:6891537.
14
Zhao Q Zhang TY Cheng YJ,et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome:results from an observational cohort study in China[J]. Cardiovasc Diabetol202019(1):108.
15
Su JY Li Z Huang MN,et al. Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease:a RCSCD-TCM study in China[J]. Cardiovasc Diabetol202221(1):96.
16
Yu XW Wang L Zhang WC,et al. Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population:a nationwide study[J]. J Diabetes Investig201910(4):1050-1058.
17
Simental-Mendía LE Rodríguez-Morán M Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord20086(4):299-304.
18
Yu J Mehran R Grinfeld L,et al. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction:three year results from the HORIZONS-AMI trial[J]. Catheter Cardiovasc Interv201585(3):359-368.
19
Lee SH Choi J Chang YJ,et al. Sex difference in long-term clinical outcomes after percutaneous coronary intervention:a propensity-matched analysis of National Health Insurance data in Republic of Korea[J]. Catheter Cardiovasc Interv202198(2):171-180.
20
Zhang S Diao J Qi CM,et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention:a meta-analysis[J]. BMC Cardiovasc Disord201818(1):75.
21
Yuan T Aisan A Maheshati T,et al. Predictive value of combining leucocyte and platelet counts for mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention treatment in Chinese population:a retrospective cohort study[J]. BMJ Open202313(7):e060756.
22
Choi DH Kobayashi Y Nishi T,et al. Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention[J]. Angiology201970(4):345-351.
23
Kattel S Bhatt H Gurung S,et al. Elevated myocardial wall stress after percutaneous coronary intervention in acute ST elevation myocardial infraction is associated with increased mortality[J]. Echocardiography202138(8):1263-1271.
24
Wongtrakul W Charoenngam N Ungprasert P. Tuberculosis and risk of coronary heart disease:a systematic review and meta-analysis[J]. Indian J Tuberc202067(2):182-188.
25
Chyrchel M Gallina T Januszek R,et al. The reduction of left ventricle ejection fraction after multi-vessel PCI during acute myocardial infarction as a predictor of major adverse cardiac events in long-term follow-up[J]. Int J Environ Res Public Health202219(20):13160.
26
Jenča D Melenovský V Stehlik J,et al. Heart failure after myocardial infarction:incidence and predictors[J]. ESC Heart Fail20218(1):222-237.
27
Chen G Feng YQ,et al. Stress induced hyperglycemia in the context of acute coronary syndrome:definitions,interventions,and underlying mechanisms[J]. Front Cardiovasc Med20218:676892.
28
Xu W Yang YM Zhu J,et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction:insights from a multi-center observational study[J]. Cardiovasc Diabetol202221(1):48.
29
Feige K Roth S M’Pembele R,et al. Influence of short and long hyperglycemia on cardioprotection by remote ischemic preconditioning-a translational approach[J]. Int J Mol Sci202223(23):14557.
30
Ceriello A Giugliano D Quatraro A,et al. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans[J]. Metabolism198938(12):1162-1163.
31
Zhu Y Liu KS Meng S,et al. Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction[J]. Cardiovasc Diabetol202019(1):101.

基金

河北大学附属医院院内基金资助项目(2023QB12)
河北大学附属医院院内基金资助项目(2021Q008)

评论

PDF(822 KB)

Accesses

Citation

Detail

段落导航
相关文章

/